Ivan Kairatov is a leading biopharma expert with a deep specialization in the intersection of artificial intelligence and immunology. With an extensive background in research and development, he has spent years navigating the complexities of how technology can accelerate drug discovery and vaccine
The overwhelming biological disparity between male and female glioblastoma outcomes has long suggested that sex hormones play a foundational role in the aggressive progression of this lethal brain cancer. Glioblastoma multiforme remains one of the most formidable challenges in modern neuro-oncology
The persistent urge to consume calorie-dense foods often has little to do with actual nutritional deficits and everything to do with how our internal circuitry processes pleasure. While the first generation of weight-loss medications focused primarily on the stomach and metabolic signals, a
The silent escalation of antimicrobial resistance has transformed everyday surface sanitation from a routine chore into a high-stakes battle for public health survival, forcing scientists to rethink how chemical agents are designed. As bacteria evolve faster than traditional laboratory methods can
In the intricate world of pediatric neurology, the sudden onset of life-threatening seizures in a previously healthy infant remains one of the most harrowing experiences for families and clinicians alike. Dravet syndrome, a severe form of epilepsy that typically surfaces during the first twelve
When a child is diagnosed with a serious condition like Wilms tumor, parents often face the agonizing decision of whether to seek treatment at a massive urban teaching hospital or a smaller local specialist center. This dilemma stems from the assumption that higher patient volumes and larger
